RT Journal Article
SR Electronic
A1 So, Derek
T1 Point-of-Care Genetic Testing Facilitates Rapid Personalization of Antiplatelet Therapy
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 14
SP 8
OP 9
DO 10.1177/155989771114006
UL http://mdc.sagepub.com/content/11/14/8.abstract
AB The primary objective of the Reassessment of Antiplatelet Therapy using an Individualized Strategy Based on Genetic Evaluation [RAPID GENE; NCT01184300] study was to evaluate the feasibility and test characteristics of a nurse-operated POC genetic test to determine CYP2C19*2 carrier status.